GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $998,000 | -14.8% | 22,937 | -14.7% | 0.01% | +10.0% |
Q1 2022 | $1,172,000 | -31.9% | 26,898 | -31.0% | 0.01% | -28.6% |
Q4 2021 | $1,720,000 | +15.7% | 39,005 | +0.3% | 0.01% | +7.7% |
Q3 2021 | $1,486,000 | +10.8% | 38,883 | +15.5% | 0.01% | +8.3% |
Q2 2021 | $1,341,000 | -96.3% | 33,679 | -96.7% | 0.01% | -95.5% |
Q1 2021 | $35,918,000 | -51.9% | 1,006,394 | -50.4% | 0.27% | +8.6% |
Q4 2020 | $74,686,000 | – | 2,029,530 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |